Ichnos Glenmark Announces Promising Phase I Results for ISB 830, a Potential Breakthrough Treatment for Multiple Myeloma
Ichnos Glenmark to Present Phase I Study Data for Myeloma Drug Candidate ISB 830 Ichnos Glenmark, a subsidiary of Glenmark…
Articles fromt he top expert of Healthcare Industry with deep analysis and propspects. Read here with TISHHA
Ichnos Glenmark to Present Phase I Study Data for Myeloma Drug Candidate ISB 830 Ichnos Glenmark, a subsidiary of Glenmark…
OmniActive Acquires ENovate Biolife to Strengthen Its Position in the Dietary Supplement Space OmniActive Health Technologies, a global leader in…
Biosensor technology can help in the early detection of kidney diseases – know all about this innovation. Scientists have developed…
Cancer immunotherapy has revolutionized the treatment landscape for many patients battling various forms of cancer. By harnessing the body’s immune…
Plastic Device Aids Robot-Assisted Heart Surgery: A Game Changer for Precision and Efficiency Plastic Device designed to assist in robot-assisted…
Hip Implant Materials with the Lowest Risk of Needing Revision Identified in New Study Hip implants, a common solution for…
Obesity is increasingly being recognized by health experts as a chronic disease that requires comprehensive management and long-term care. Despite…
Advanced Brain Device Offers New Hope for Parkinson’s Patients in India Advanced brain device technology is revolutionizing the treatment of…
Chikungunya Cases on the Rise in Kolkata Amid Testing Challenges: Doctors Warn of Growing Concern Chikungunya cases are surging in…
PFAS Chemicals May Cut Kidney Function by 50%, Harm Gut Health: Study PFAS Chemicals – commonly known as “forever chemicals”…